Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) Profit Margin

The latest profit margin for ELAT is -3.96% as of June 2026. That compares with 41.36% in the prior-year period — down 109.6% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ELAT's profit margin moved from 41.36% to -3.96% — a 109.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s valuation or profitability profile.

Against Healthcare companies, ELAT currently prints -3.96% for profit margin, while the sector average sits near 21.34%. That is roughly 118.6% below the sector mean. Large gaps often invite a closer look at Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) converts resources into returns. At -3.96%, ELAT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 41.36% in the prior-year period — down 109.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ELAT's profit margin (-3.96%), review year-over-year change from 41.36%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.